MedTrace Logo

Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females

NCT02604888 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-01-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Alopecia Areata.

Conditions

Interventions

OTHER

MEXIS/M6S Patent - lotion against alopecia

For greatest problems 20 drops on the scalp per day for 6 months. For minor problems 10 drops on the scalp three times per week for 6 months.

Sponsors & Collaborators

  • Mexis George

    lead OTHER

Principal Investigators

  • Markos Papakonstantis, Monitor · 401 General Military Hospital of Athens, Dermatology clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-10-31
Completion
2017-10-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02604888 on ClinicalTrials.gov